Expression of the major and pro-oncogenic H3K9 lysine methyltransferase SETDB1 in non-small cell lung cancer

SETDB1 is a key histone lysine methyltransferase involved in gene silencing. The SETDB1 gene is amplified in human lung cancer, where the protein plays a driver role. Here, we investigated the clinical significance of SETDB1 expression in the two major forms of human non-small cell lung carcinoma (N...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2019
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23638
Acceso en línea:
https://doi.org/10.3390/cancers11081134
https://repository.urosario.edu.co/handle/10336/23638
Palabra clave:
Histone lysine methyltransferase
Messenger rna
Setdb1 protein
Unclassified drug
Article
Controlled study
Disease association
Female
Gene
Human
Human tissue
Lung adenocarcinoma
Major clinical study
Male
Non small cell lung cancer
Pathology
Protein expression
Setdb1 gene
Smoking
Squamous cell lung carcinoma
Transcriptomics
Lysine methyltransferase
Meta-analysis
Non-small cell lung cancer
Setdb1/kmt1e
Rights
License
Abierto (Texto Completo)
id EDOCUR2_045c5796abc1f5dba75591bdc2480403
oai_identifier_str oai:repository.urosario.edu.co:10336/23638
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 8e1a98cb-2d78-4910-a36d-9d4982bf6ab6-124f82797-0d0a-4fb1-a826-aacbf419b54d-1b4fedd40-bdff-4c0a-a81c-f58bf142177c-1e566432b-7ed0-4aed-8451-8e07e2d65b63-14e6c4eaa-cb61-473e-aefe-889f587ee4cd-1518662516002020-05-26T00:03:54Z2020-05-26T00:03:54Z2019SETDB1 is a key histone lysine methyltransferase involved in gene silencing. The SETDB1 gene is amplified in human lung cancer, where the protein plays a driver role. Here, we investigated the clinical significance of SETDB1 expression in the two major forms of human non-small cell lung carcinoma (NSCLC), i.e., adenocarcinoma (ADC) and squamous cell carcinoma (SCC), by combining a meta-analysis of transcriptomic datasets and a systematic review of the literature. A total of 1140 NSCLC patients and 952 controls were included in the association analyses. Our data revealed higher levels of SETDB1 mRNA in ADC (standardized mean difference, SMD: 0.88; 95% confidence interval, CI: 0.73–1.02; p less than 0.001) and SCC (SMD: 0.40; 95% CI: 0.13–0.66; p = 0.003) compared to non-cancerous tissues. For clinicopathological analyses, 2533 ADC and 903 SCC patients were included. Interestingly, SETDB1 mRNA level was increased in NSCLC patients who were current smokers compared to non-smokers (SMD: 0.26; 95% CI: 0.08–0.44; p = 0.004), and when comparing former smokers and non-smokers (p = 0.009). Furthermore, the area under the curve (AUC) given by the summary receiver operator characteristic curve (sROC) was 0.774 (Q = 0.713). Together, our findings suggest a strong foundation for further research to evaluate SETDB1 as a diagnostic biomarker and/or its potential use as a therapeutic target in NSCLC. © 2019 by the authors. Licensee MDPI, Basel, Switzerland.application/pdfhttps://doi.org/10.3390/cancers1108113420726694https://repository.urosario.edu.co/handle/10336/23638engMDPI AGNo. 8CancersVol. 11Cancers, ISSN:20726694, Vol.11, No.8 (2019)https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071090308&doi=10.3390%2fcancers11081134&partnerID=40&md5=908d6e3bc6c0319f5c508e96dfe7ce72Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURHistone lysine methyltransferaseMessenger rnaSetdb1 proteinUnclassified drugArticleControlled studyDisease associationFemaleGeneHumanHuman tissueLung adenocarcinomaMajor clinical studyMaleNon small cell lung cancerPathologyProtein expressionSetdb1 geneSmokingSquamous cell lung carcinomaTranscriptomicsLysine methyltransferaseMeta-analysisNon-small cell lung cancerSetdb1/kmt1eExpression of the major and pro-oncogenic H3K9 lysine methyltransferase SETDB1 in non-small cell lung cancerarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Cruz-Tapias, PaolaZakharova, VladaPerez-Fernandez, Oscar MMantilla, WilliamAit-Si-Ali, SlimaneRamírez Clavijo, Sandra RocíoORIGINALcancers-11-01134-v3.pdfapplication/pdf3005528https://repository.urosario.edu.co/bitstreams/55ef7276-14bd-47e0-a515-6af1f7d6274a/download6f2638bb3c2519cfae130e416172bd2cMD51TEXTcancers-11-01134-v3.pdf.txtcancers-11-01134-v3.pdf.txtExtracted texttext/plain69582https://repository.urosario.edu.co/bitstreams/a30bc302-6a6e-48ed-9d1e-c3e969fa9c33/download8d4a750c8d4c728936a61dc0afee7911MD52THUMBNAILcancers-11-01134-v3.pdf.jpgcancers-11-01134-v3.pdf.jpgGenerated Thumbnailimage/jpeg4969https://repository.urosario.edu.co/bitstreams/ed2930d3-16a0-4c7d-962b-dda289b8438b/download500811374616363f3e3d3f64f900e537MD5310336/23638oai:repository.urosario.edu.co:10336/236382022-05-02 07:37:14.763543https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Expression of the major and pro-oncogenic H3K9 lysine methyltransferase SETDB1 in non-small cell lung cancer
title Expression of the major and pro-oncogenic H3K9 lysine methyltransferase SETDB1 in non-small cell lung cancer
spellingShingle Expression of the major and pro-oncogenic H3K9 lysine methyltransferase SETDB1 in non-small cell lung cancer
Histone lysine methyltransferase
Messenger rna
Setdb1 protein
Unclassified drug
Article
Controlled study
Disease association
Female
Gene
Human
Human tissue
Lung adenocarcinoma
Major clinical study
Male
Non small cell lung cancer
Pathology
Protein expression
Setdb1 gene
Smoking
Squamous cell lung carcinoma
Transcriptomics
Lysine methyltransferase
Meta-analysis
Non-small cell lung cancer
Setdb1/kmt1e
title_short Expression of the major and pro-oncogenic H3K9 lysine methyltransferase SETDB1 in non-small cell lung cancer
title_full Expression of the major and pro-oncogenic H3K9 lysine methyltransferase SETDB1 in non-small cell lung cancer
title_fullStr Expression of the major and pro-oncogenic H3K9 lysine methyltransferase SETDB1 in non-small cell lung cancer
title_full_unstemmed Expression of the major and pro-oncogenic H3K9 lysine methyltransferase SETDB1 in non-small cell lung cancer
title_sort Expression of the major and pro-oncogenic H3K9 lysine methyltransferase SETDB1 in non-small cell lung cancer
dc.subject.keyword.spa.fl_str_mv Histone lysine methyltransferase
Messenger rna
Setdb1 protein
Unclassified drug
Article
Controlled study
Disease association
Female
Gene
Human
Human tissue
Lung adenocarcinoma
Major clinical study
Male
Non small cell lung cancer
Pathology
Protein expression
Setdb1 gene
Smoking
Squamous cell lung carcinoma
Transcriptomics
Lysine methyltransferase
Meta-analysis
Non-small cell lung cancer
Setdb1/kmt1e
topic Histone lysine methyltransferase
Messenger rna
Setdb1 protein
Unclassified drug
Article
Controlled study
Disease association
Female
Gene
Human
Human tissue
Lung adenocarcinoma
Major clinical study
Male
Non small cell lung cancer
Pathology
Protein expression
Setdb1 gene
Smoking
Squamous cell lung carcinoma
Transcriptomics
Lysine methyltransferase
Meta-analysis
Non-small cell lung cancer
Setdb1/kmt1e
description SETDB1 is a key histone lysine methyltransferase involved in gene silencing. The SETDB1 gene is amplified in human lung cancer, where the protein plays a driver role. Here, we investigated the clinical significance of SETDB1 expression in the two major forms of human non-small cell lung carcinoma (NSCLC), i.e., adenocarcinoma (ADC) and squamous cell carcinoma (SCC), by combining a meta-analysis of transcriptomic datasets and a systematic review of the literature. A total of 1140 NSCLC patients and 952 controls were included in the association analyses. Our data revealed higher levels of SETDB1 mRNA in ADC (standardized mean difference, SMD: 0.88; 95% confidence interval, CI: 0.73–1.02; p less than 0.001) and SCC (SMD: 0.40; 95% CI: 0.13–0.66; p = 0.003) compared to non-cancerous tissues. For clinicopathological analyses, 2533 ADC and 903 SCC patients were included. Interestingly, SETDB1 mRNA level was increased in NSCLC patients who were current smokers compared to non-smokers (SMD: 0.26; 95% CI: 0.08–0.44; p = 0.004), and when comparing former smokers and non-smokers (p = 0.009). Furthermore, the area under the curve (AUC) given by the summary receiver operator characteristic curve (sROC) was 0.774 (Q = 0.713). Together, our findings suggest a strong foundation for further research to evaluate SETDB1 as a diagnostic biomarker and/or its potential use as a therapeutic target in NSCLC. © 2019 by the authors. Licensee MDPI, Basel, Switzerland.
publishDate 2019
dc.date.created.spa.fl_str_mv 2019
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:03:54Z
dc.date.available.none.fl_str_mv 2020-05-26T00:03:54Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.3390/cancers11081134
dc.identifier.issn.none.fl_str_mv 20726694
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/23638
url https://doi.org/10.3390/cancers11081134
https://repository.urosario.edu.co/handle/10336/23638
identifier_str_mv 20726694
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationIssue.none.fl_str_mv No. 8
dc.relation.citationTitle.none.fl_str_mv Cancers
dc.relation.citationVolume.none.fl_str_mv Vol. 11
dc.relation.ispartof.spa.fl_str_mv Cancers, ISSN:20726694, Vol.11, No.8 (2019)
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071090308&doi=10.3390%2fcancers11081134&partnerID=40&md5=908d6e3bc6c0319f5c508e96dfe7ce72
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv MDPI AG
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
bitstream.url.fl_str_mv https://repository.urosario.edu.co/bitstreams/55ef7276-14bd-47e0-a515-6af1f7d6274a/download
https://repository.urosario.edu.co/bitstreams/a30bc302-6a6e-48ed-9d1e-c3e969fa9c33/download
https://repository.urosario.edu.co/bitstreams/ed2930d3-16a0-4c7d-962b-dda289b8438b/download
bitstream.checksum.fl_str_mv 6f2638bb3c2519cfae130e416172bd2c
8d4a750c8d4c728936a61dc0afee7911
500811374616363f3e3d3f64f900e537
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1808390635013537792